Hayden Michael R: insider trades.
Hayden Michael R reported 5 non-derivative transactions on 5 SEC ownership filings in Q3 2026: 4 open-market purchases ($2.1M) and 0 sales, across 2 companies.
- Transactions
- 5
- Purchases (P)
- 4
- Sales (S)
- 0
- Companies
- 2
- Name as filed
- Hayden Michael R
Companies
| Company | Relationship | Transactions |
|---|---|---|
| AbCellera Biologics Inc. (ABCL) | Director | 3 |
| Ionis Pharmaceuticals Inc (IONS) | Director | 2 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-24 | AbCellera Biologics Inc. | P | 53,613 | $10.64 | 1,373,397 | Form 4 |
| 2026-08-12 | AbCellera Biologics Inc. | P | 46,387 | $10.37 | 1,319,784 | Form 4 |
| 2026-08-11 | AbCellera Biologics Inc. | G | 50,000 | $0 | 1,273,397 | Form 4 |
| 2026-07-31 | Ionis Pharmaceuticals Inc | P | 5,000 | $51.6 | 24,000 | Form 4 |
| 2026-07-30 | Ionis Pharmaceuticals Inc | P | 15,000 | $53.38 | 19,000 | Form 4 |
Questions
What stock did Hayden Michael R buy or sell?
Hayden Michael R reported 5 non-derivative transactions on 5 SEC ownership filings in Q3 2026: 4 open-market purchases ($2.1M) and 0 sales, across 2 companies.
Is Hayden Michael R the same person as other filers with this name?
This page covers SEC CIK 1352908 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/hayden-michael-r-1352908.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.